Zhengye Biotechnology Holding Ltd
Zhengye Biotechnology Holding Ltd (ZYBT): ~3 mo cash runway. Updated within the last hour.
BioSniper Score
2-factor signal · derived from public data
2.5 months
D/E 0.52
N/A
N/A
N/A
N/A
A transparent, data-derived signal for Zhengye Biotechnology Holding Ltdacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$38.2M
Cash
$7.2M
Quarterly Burn
$13.5M
Runway
2.5 mo
Revenue
$16.6M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
5
Total value held
$101K
| Holder | Shares | Value |
|---|---|---|
| xtx topco ltd | 44,146 | $41K |
| winton group ltd | 33,389 | $31K |
| geode capital management, llc | 29,068 | $27K |
| royal bank of canada | 1,230 | $1K |
| morgan stanley | 261 | $244 |
Frequently asked questions
What is Zhengye Biotechnology Holding Ltd's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Zhengye Biotechnology Holding Ltd has approximately 2.5 months of cash runway.
What is Zhengye Biotechnology Holding Ltd's market capitalization?
Zhengye Biotechnology Holding Ltd's market capitalization is approximately $38.2M.
Who is the CEO of Zhengye Biotechnology Holding Ltd?
Mr. Songlin Song is the chief executive officer of Zhengye Biotechnology Holding Ltd (ZYBT).
Get the full picture on Zhengye Biotechnology Holding Ltd
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.